Biotechnology
Innoforce Pharmaceuticals Opens Analytical Development and Process Development Facility in Hangzhou, China
HANGZHOU, China and ROCKVILLE, Md., Aug. 17, 2021 /PRNewswire/ -- Innoforce Pharmaceuticals ("Innoforce"), a biopharmaceutical innovation and partnership company, today announces that it has opened a new Advanced Cell and Gene Therapy Development Facility inHangzhou, China. Analytical development...
2021-08-17 19:00
1523
Ascletis' Partner Sagimet Dosed First Patient in FASCINATE-2 Phase IIb Trial in NASH Patients with Moderate to Advanced Fibrosis
HANGZHOU and SHAOXING, China, Aug. 16, 2021 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX:1672) today announces that its partner Sagimet Biosciences dosed the first patient in its FASCINATE-2 Phase IIb clinical trial for non-alcoholic steatohepatitis (NASH). FASCINATE-2 is a randomized, double-blin...
2021-08-16 21:30
2662
BioAgilytix to Purchase Australia-based 360biolabs®
Highly complementary transaction will strengthen company's ability to support bioanalytical services across all stages, development capabilities and geographies DURHAM, N.C., Aug. 16, 2021 /PRNewswire/ -- BioAgilytix Labs, LLC (BioAgilytix), a leading global contract research laboratory focused ...
2021-08-16 18:00
2576
Qiming's Portfolio Company Sino Biological Lists on Shenzhen's ChiNext Market
SHANGHAI, Aug. 16, 2021 /PRNewswire/ -- Qiming Venture Partners' portfolio company Sino Biological (SZSE: 301047) onAugust 16th listed on Shenzhen's ChiNext Market. The issue price isCNY 292.92 per share. The stock opened at CNY 599.9, up 104.8%, representing a market cap of CNY 40.79 billion. Q...
2021-08-16 14:14
2441
Sino Biological Announces Successful Closing of 4.98 Billion RMB Public Offering and Listing on the Shenzhen ChiNext Stock Exchange
BEIJING, Aug. 16, 2021 /PRNewswire/ -- Sino Biological, Inc. ("Sino Biological" or the "Company"), a biotechnology company which provides biological research reagents and related technical contract research services, announced a successful listing on the Shenzhen Stock Exchange subsidiary ChiNext...
2021-08-16 13:12
2582
TurtleTree and Solar Biotech enter strategic partnership
WOODLAND, Calif., Aug. 13, 2021 /PRNewswire/ -- Solar Biotech, led by industrial biotech expertAlex Berlin, has become a significant piece of the puzzle for sustainable food tech companies taking products to market. TurtleTree knew from the beginning that one of the biggest challenges for food t...
2021-08-13 21:00
3970
A3P Biomedical AB: Fast track publication of the STHLM3 MRI trial in The Lancet Oncology
STOCKHOLM, Aug. 13, 2021 /PRNewswire/ -- A3P Biomedical AB today announced that the publication of the STHLM3 MRI trial including 12,750 men has been fast tracked and is now published in the renowned peer-reviewed scientific publication The Lancet Oncology1. Results from the STHLM3 MRI trial, p...
2021-08-13 12:22
1503
TOT BIOPHARM Anounces 2021 Interim Results
Revenue Surges 78% to RMB23.13 million CDMO Business Achieves Leapfrog Breakthrough Two Products Approved for Launch Smooth Progress of Various Core Anti-tumor Drugs Clinical Trials To Allocate Resources to Boost Innovative ADC Drugs HONG KONG and SUZHOU, China, Aug. 13, 2021 /PRNewswire/ -- TOT B...
2021-08-13 10:59
19073
Innovent Announces IBI306 (anti-PCSK-9 antibody) Meets the Primary Endpoint in a Phase 3 Clinical Study for Chinese Heterozygous Familial Hypercholesterolemia
SAN FRANCISCO and SUZHOU, China, Aug. 12, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major dise...
2021-08-12 08:00
8996
Lynk Pharmaceuticals Announced First Patient Dosed in Phase I Clinical Study of Its Triple-Kinase Inhibitor LNK01002
HANGZHOU, China, Aug. 12, 2021 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as 'Lynk Pharmaceuticals'), an innovative drug development company, announced today that it has administered its triple-kinase inhibitor LNK01002 to the first patient in a phase I clinical trial...
2021-08-12 08:00
3240
The Former Director of the Center for Drug Evaluation and Research at FDA and R&D Leader at Amgen, Steven Galson Joins Insilico Medicine as Independent Director
HONG KONG, Aug. 11, 2021 /PRNewswire/ -- Insilico Medicine, a global leader in end-to-end AI-powered drug discovery, today announced the appointment ofSteven Galson, MD, MPH as the independent member of the board of directors. "Successful drug development depends on speed and increasing the rates...
2021-08-11 20:31
2356
Technology Investments will Help Oncology Practices Succeed in Value-based Care
Frost & Sullivan's latest article highlights steps to transition to an Oncology Care First model SANTA CLARA, Calif., Aug. 11, 2021 /PRNewswire/ -- Community oncology practices are continuing to adapt to value-based reimbursement models as the Centers for Medicare and Medicaid Services (CMS) pre...
2021-08-11 18:02
1236
INDICAID(TM) COVID-19 Rapid Antigen Test Receives Emergency Use Authorization From the U.S. Food and Drug Administration
HONG KONG and GARDEN GROVE, Calif., Aug. 11, 2021 /PRNewswire/ -- PHASE
Scientific International LTD
2021-08-11 01:00
2805
NewYork-Presbyterian, LiveOnNY and Transplant Connect Launch iReferral(SM) Automated Donor Referral Technology to Increase Donation and Transplantation across New York City
Collaboration around new innovative technology improves processes and may help save lives inNew York through donation and transplantation NEW YORK, Aug. 10, 2021 /PRNewswire/ -- NewYork-Presbyterian, together with LiveOnNY, the nonprofit organ procurement organization (OPO) for the greaterNew Yo...
2021-08-10 21:32
1676
Prenetics and New World Development Launch Circle HealthPod, the World's Most Advanced At-Home Covid-19 test
* Circle HealthPod is a Rapid Detection System for all infectious diseases, starting with Covid-19 and will include Flu and STDs in the future * Technology developed at University of Oxford, with PCR quality results in 20 minutes * Circle HealthPod, having received CE-IVD marking, is a reusa...
2021-08-10 07:00
4405
Insilico Medicine Announces an AI-driven PROTAC R&D Collaboration with Arvinas
HONG KONG, Aug. 9, 2021 /PRNewswire/ -- Insilico Medicine is proud to announce an R&D collaboration with Arvinas (NASDAQ: ARVN). This strategic partnership will involve Insilico Medicine's AI-augmented platforms and close cooperation between Arvinas' and Insilico Medicine's scientists on novel PR...
2021-08-09 21:47
2825
YishengBio Announces PIKA recombinant COVID-19 vaccine received Phase I clinical trial IND clearance from New Zealand
BEIJING, Aug. 9, 2021 /PRNewswire/ -- YishengBio Co., Ltd ("YishengBio") today announced that it received IND clearance for PIKA recombinant COVID-19 vaccine (CHO cell, S Protein) to conduct Phase I clinical trial from New Zealand Medicines and Medical Devices Safety Authority ("MEDSAFE"), which ...
2021-08-09 21:00
2647
Life Sciences' Contribution to the US Digital Therapeutics Market to Grow the Fastest amongst all End Users
The US digital therapeutics market is estimated to witness more than three-and-a-half-fold growth reaching$4.54 billion by 2025, at a CAGR of 29.8%, finds Frost & Sullivan SANTA CLARA, Calif., Aug. 9, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis finds that digital therapeutics (DTx) i...
2021-08-09 18:02
2241
Thailand's Jan-June Investment Applications Reach USD12 billion, as FDI Quadruple, E&E and Medical Sectors Continue to Expand, BOI says
BANGKOK, Aug. 9, 2021 /PRNewswire/ -- In the first six months of 2021, Thailand's investment applications increased 14% from the year earlier period in terms of the number of projects, and 158% in combined value, led by increasing foreign direct investment (FDI) applications, sustained growth in ...
2021-08-09 15:35
1942
Antengene and MindRank AI Enter into Collaboration to Advance the Development of Difficult-to-Drug Molecular Targets
SHANGHAI and HONG KONG, Aug. 9, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncolo...
2021-08-09 08:30
2727
Week's Top Stories
Most Reposted
Getac Announces World's First AI-Ready Rugged Laptop
[Picked up by 308 media titles]
2024-05-29 08:00
Aetina Showcases Next-Gen Edge AI Solutions at COMPUTEX 2024
[Picked up by 301 media titles]
2024-05-30 15:00China accelerates construction of intelligent ports
[Picked up by 284 media titles]
2024-05-27 09:00Meiyume Debuts at Cosmoprof CBE Asean Bangkok: Pioneering the Future of Beauty Innovation with Sustainability and Smart Technology
[Picked up by 284 media titles]
2024-05-28 14:00
RF Acquisition Corp II Announces Pricing of $100 Million Initial Public Offering
[Picked up by 274 media titles]
2024-05-29 14:21Most Read
Getac Announces World's First AI-Ready Rugged Laptop
2024-05-29 08:00
7583
China accelerates construction of intelligent ports
2024-05-27 09:00
6321
RF Acquisition Corp II Announces Pricing of $100 Million Initial Public Offering
2024-05-29 14:21
5655
